Impact of cigarette smoking on outcome of hepatocellular carcinoma after surgery in patients with hepatitis B

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Zhang, Xu Feng ^a   Wei, Tao ^a   Liu, Xue Min ^a   Liu, Chang ^a   Lv, Yi ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BLOOD TRANSFUSION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; RECURRENCE FREE SURVIVAL; SMOKING CESSATION; SMOKING HABIT; SURGICAL TECHNIQUE; SURVIVAL TIME; TUMOR VOLUME; CARCINOMA, HEPATOCELLULAR; COMPLICATION; LIVER NEOPLASMS; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; RECURRENT DISEASE; SMOKING; TOBACCO;

CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; SMOKING; TOBACCO;

EID: 84898621354     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085077     Document Type: Article

References (36)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2 (Pubitemid 40372904)
2. Chen JG, Zhang SW, Chen WQ (2010) Analysis of liver cancer mortality in the national retrospective sampling survey of death causes in China, 2004-2005. Chin J Prev Med 44:383-389.
3. Kao JH, Chen DS (2002) Recent research progress in hepatocellular carcinoma. J Formos Med Assoc 101:239-248.
4. Yu MC, Yuan JM, Govindarajan S, Ross RK (2000) Epidemiology of hepatocellular carcinoma. Can J Gastroenterol 14:703-709.
5. Koh WP, Robien K, Wang R, Govindarajan S, Yuan JM, et al. (2011) Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study. Br J Cancer 105:1430-1435.
6. Koh WP, Yuan JM, Sun CL, Lee HP, Yu MC (2005) Middle-aged and older Chinese men and women in Singapore who smoke have less healthy diets and lifestyles than nonsmokers. J Nutr 135:2473-2477. (Pubitemid 41429610)
7. El-Zayadi AR (2006) Heavy smoking and liver. World J Gastroenterol 12:6098-6101.
8. Wang LY, Chen CJ, Zhang YJ, Tsai WY, Lee PH, et al. (1998) 4-Aminobiphenyl DNA damage in liver tissue of hepatocellular carcinoma patients and controls. Am J Epidemiol 147:315-323.
9. Helen A, Vijayammal PL (1997) Vitamin C supplementation on hepatic oxidative stress induced by cigarette smoke. J Appl Toxicol 17:289-295. (Pubitemid 27400067)
10. Grosse Y, Baan R, Straif K, Secretan B, El Ghissassi F, et al. (2007) Carcinogenicity of 1, 3-butadiene, ethylene oxide, vinyl chloride, vinyl fluoride, and vinyl bromide. Lancet Oncol 8:679-680.
11. Moller AM, Villebro N, Pedersen T, Tonnesen H (2002) Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 359:114-117. (Pubitemid 34112539)
12. Lindstrom D, Sadr Azodi O, Wladis A, Tonnesen H, Linder S, et al. (2008) Effects of a perioperative smoking cessation intervention on postoperative complications: a randomized trial. Ann Surg 248:739-745.
13. Joshu CE, Mondul AM, Meinhold CL, Humphreys EB, Han M, et al. (2011) Cigarette smoking and prostate cancer recurrence after prostatectomy. J Natl Cancer Inst 103:835-838.
14. Phipps AI, Shi Q, Newcomb PA, Nelson GD, Sargent DJ, et al. (2013) Associations between cigarette smoking status and colon cancer prognosis among participants in North Central Cancer Treatment Group Phase III Trial N0147. J Clin Oncol 31:2016-2023.
15. Hagiwara M, Kikuchi E, Tanaka N, Matsumoto K, Ide H, et al. (2013) Impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma. J Urol 189:2062-2068.
16. Smyth EC, Capanu M, Janjigian YY, Kelsen DK, Coit D, et al. (2012) Tobacco use is associated with increased recurrence and death from gastric cancer. Ann Surg Oncol 19:2088-2094.
17. Shih WL, Chang HC, Liaw YF, Lin SM, Lee SD, et al. (2012) Influences of tobacco and alcohol use on hepatocellular carcinoma survival. Int J Cancer 131:2612-2621.
18. Chuang SC, Lee YC, Hashibe M, Dai M, Zheng T, et al. (2010) Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 19:1261-1268.
19. Lok AS, McMahon BJ (2001) Practice Guidelines Committee AASLD. Chronic hepatitis B. Hepatology 34:1225-41.
20. Lok AS, McMahon BJ (2004) Practice Guidelines Committee AASLD. Chronic hepatitis B: update of recommendations. Hepatology 39:857-61. (Pubitemid 38337668)
21. Chen ZM, Liu BQ, Boreham J, Wu YP, Chen JS, et al. (2003) Smoking and liver cancer in China: case-control comparison of 36, 000 liver cancer deaths vs. 17, 000 cirrhosis deaths. Int J Cancer 107:106-112. (Pubitemid 37100093)
22. Liaw KM, Chen CJ (1998) Mortality attributable to cigarette smoking in Taiwan: a 12-year follow-up study. Tob Control 7:141-148.
23. Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, et al. (2005) Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42:218-224. (Pubitemid 40143468)
24. Nagle CM, Bain CJ, Webb PM (2006) Cigarette smoking and survival after ovarian cancer diagnosis. Cancer Epidemiol Biomarkers Prev 15:2557-2560. (Pubitemid 46048322)
25. Peters MG, Terrault NA (2002) Alcohol use and hepatitis C. Hepatology 36:S220-225. (Pubitemid 35253484)
26. Zhang XF, Meng B, Qi X, Yu L, Liu C, et al. (2009) Prognostic factors after liver resection for hepatocellular carcinoma with hepatitis B virus-related cirrhosis: surgeon's role in survival. Eur J Surg Oncol 35:622-628.
27. Sanchez-Cespedes M, Ahrendt SA, Piantadosi S, Rosell R, Monzo M, et al. (2001) Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers. Cancer Res 61:1309-1313. (Pubitemid 34292548)
28. Tammemagi MC, McLaughlin JR, Mullen JB, Bull SB, Johnston MR, et al. (2000) A study of smoking, p53 tumor suppressor gene alterations and non-small cell lung cancer. Ann Epidemiol 10:176-185. (Pubitemid 30171275)
29. Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF, et al. (1999) A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology 29:697-702.
30. Rudin CM, Avila-Tang E, Harris CC, Herman JG, Hirsch FR, et al. (2009) Lung cancer in never smokers: molecular profiles and therapeutic implications. Clin Cancer Res 15:5646-5661.
31. Janjigian YY, McDonnell K, Kris MG, Shen R, Sima CS, et al. (2010) Packyears of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer. Cancer 116:670-675.
32. Azzalini L, Ferrer E, Ramalho LN, Moreno M, Dominguez M, et al. (2010) Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats. Hepatology 51:1567-1576.
33. Hezode C, Lonjon I, Roudot-Thoraval F, Mavier JP, Pawlotsky JM, et al. (2003) Impact of smoking on histological liver lesions in chronic hepatitis C. Gut 52:126-129. (Pubitemid 36020778)
34. Pessione F, Ramond MJ, Njapoum C, Duchatelle V, Degott C, et al. (2001) Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology 34:121-125. (Pubitemid 32591491)
35. Altamirano J, Bataller R (2010) Cigarette smoking and chronic liver diseases. Gut 59:1159-1162.
36. Giovannucci E, Rimm EB, Ascherio A, Colditz GA, Spiegelman D, et al. (1999) Smoking and risk of total and fatal prostate cancer in United States health professionals. Cancer Epidemiol Biomarkers Prev 8:277-282. (Pubitemid 29193896)